These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 19557470)

  • 21. Dapoxetine: in premature ejaculation.
    Hoy SM; Scott LJ
    Drugs; 2010 Jul; 70(11):1433-43. PubMed ID: 20614950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review.
    Russo A; Capogrosso P; Ventimiglia E; La Croce G; Boeri L; Montorsi F; Salonia A
    Int J Clin Pract; 2016 Sep; 70(9):723-33. PubMed ID: 27456527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial.
    Kaufman JM; Rosen RC; Mudumbi RV; Tesfaye F; Hashmonay R; Rivas D
    BJU Int; 2009 Mar; 103(5):651-8. PubMed ID: 19021601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights on premature ejaculation: a review of definition, classification, prevalence and treatment.
    Serefoglu EC; Saitz TR
    Asian J Androl; 2012 Nov; 14(6):822-9. PubMed ID: 23064688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation.
    Andersson KE; Mulhall JP; Wyllie MG
    BJU Int; 2006 Feb; 97(2):311-5. PubMed ID: 16430636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries.
    Buvat J; Tesfaye F; Rothman M; Rivas DA; Giuliano F
    Eur Urol; 2009 Apr; 55(4):957-67. PubMed ID: 19195772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging drugs for premature ejaculation.
    Waldinger MD
    Expert Opin Emerg Drugs; 2006 Mar; 11(1):99-109. PubMed ID: 16503829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The characterization, current medications, and promising therapeutics targets for premature ejaculation.
    Gur S; Sikka SC
    Andrology; 2015 May; 3(3):424-42. PubMed ID: 25951512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing satisfaction in men with premature ejaculation after dapoxetine treatment in real-world practice.
    Jiann BP; Huang YJ
    Int J Clin Pract; 2015 Nov; 69(11):1326-33. PubMed ID: 26194604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does lidocaine ointment addition increase fluoxetine efficacy in the same group of patients with premature ejaculation?
    Metin A; Kayigil O; Ahmed SI
    Urol Int; 2005; 75(3):231-4. PubMed ID: 16215311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials.
    Pryor JL; Althof SE; Steidle C; Rosen RC; Hellstrom WJ; Shabsigh R; Miloslavsky M; Kell S;
    Lancet; 2006 Sep; 368(9539):929-37. PubMed ID: 16962882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials.
    McMahon CG; Althof SE; Kaufman JM; Buvat J; Levine SB; Aquilina JW; Tesfaye F; Rothman M; Rivas DA; Porst H
    J Sex Med; 2011 Feb; 8(2):524-39. PubMed ID: 21059176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of physical activity on patient self-reported outcomes of lifelong premature ejaculation patients: Results of a prospective, randomised, sham-controlled trial.
    Kilinc MF; Aydogmus Y; Yildiz Y; Doluoglu OG
    Andrologia; 2018 Feb; 50(1):. PubMed ID: 28261848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation.
    Pastore AL; Palleschi G; Leto A; Pacini L; Iori F; Leonardo C; Carbone A
    Int J Androl; 2012 Aug; 35(4):528-33. PubMed ID: 22320846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central regulation of ejaculation and the therapeutic role of serotonergic agents in premature ejaculation.
    Patel K; Hellstrom WJ
    Curr Opin Investig Drugs; 2009 Jul; 10(7):681-90. PubMed ID: 19579174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dapoxetine treatment of premature ejaculation.
    Waldinger MD; Schweitzer DH; Olivier B
    Lancet; 2006 Nov; 368(9550):1869; author reply 1869-70. PubMed ID: 17126717
    [No Abstract]   [Full Text] [Related]  

  • 37. Current Pharmacological Management of Premature Ejaculation: A Systematic Review and Meta-analysis.
    Castiglione F; Albersen M; Hedlund P; Gratzke C; Salonia A; Giuliano F
    Eur Urol; 2016 May; 69(5):904-16. PubMed ID: 26749092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral dapoxetine versus topical lidocaine as on-demand treatment for lifelong premature ejaculation: A randomised controlled trial.
    Alghobary M; Gaballah M; El-Kamel MF; State AF; Ismail SR; Selim MK; Mostafa T
    Andrologia; 2020 Jun; 52(5):e13558. PubMed ID: 32153050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.
    Safarinejad MR
    Clin Neuropharmacol; 2006; 29(5):243-52. PubMed ID: 16960468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dapoxetine in treatment of premature ejaculation: a systematic review].
    Wang YB; Mao Y; Wei Q; Wu TX; Dong Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):425-32. PubMed ID: 20721257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.